PVR and dermatomyositis: TIGIT (CD155) is a recently identified immune checkpoint expressed in both T and NK cell, in agreement with our expression correlation analysis: its higher expression in irMyositis compared to DM makes it a druggable candidate whose role in immunotherapy-induced conditions such as irMyositis should be further assessed in future studies46.